Strontium ranelate: A new effective antiosteoporotic treatment reducing the incidence of vertebral and non vertebral fractures in postmenopausal women with osteoporosis

被引：0

作者：

Reginster, JY

Hoszowski, K

Varela, AR

Balogh, A

Clements, M

Fiore, C

Cormier, C

Schmidt, WE

Jensen, JB

Prince, R

Raeman, F

Rizzoli, R

Meunier, PJ

机构：

[1] Univ Liege, Bone & Cartilage Unit, Liege, Belgium

[2] Univ Liege, WHO, Collaborating Ctr Publ Hlth Aspects Osteoarticula, Dept Epidemiol & Publ Hlth, Liege, Belgium

[3] Railway Hosp, Dept Internal Med, Warsaw, Poland

[4] Nuestra Sra Candelaria Hosp, Consultas Externas Reumatol, Tenerife, Spain

[5] Univ Debrecen, Med & Hlth Sci Ctr, Dept Obstet & Gynaecol, H-4012 Debrecen, Hungary

[6] N London Clin Studies Ctr, London, England

[7] Vittorio Emanuele Hosp, Catania, Italy

[8] Hop Cochin, Dept Rheumatol, F-75674 Paris, France

[9] Ruhr Univ Bochum, St Josef Hosp, Sch Med, Dept Med, D-4630 Bochum, Germany

[10] Cent Hosp Hillerod, Dept Clin Physiol, Hillerod, Denmark

[11] Sir Charles Gairdner Hosp, Dept Med, Perth, WA, Australia

[12] Jan Palfijn Zeikenhuis, Dept Rheumatol, Merksem, Belgium

[13] Univ Hosp Geneva, Dept Internal Med, Div Bone Dis, Geneva, Switzerland

[14] Univ Hosp Geneva, Sch Dent, Geneva, Switzerland

[15] Hop Edouard Herriot, Dept Rheumatol & Bone Dis, Lyon, France

来源：

BONE | 2003年 / 32卷 / 05期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：S94 / S94

页数：1

共 50 条

[41] Strontium ranelate: long-term efficacy against vertebral, nonvertebral and hip fractures in patients with postmenopausal osteoporosis
Reginster, Jean-Yves
Hiligsmann, Mickael
Bruyere, Olivier
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2010, 3 (03) : 133 - U41
[42] Strontium ranelate reduces the risk of vertebral fractures in postemenopausal women with osteopenia
Sawicki, A
Reginster, JY
Roux, C
Rubinacci, A
Diaz-Curiel, M
Kaufman, J
Seeman, E
De Vernejoul, MC
Aquino, JP
Meunier, PJ
OSTEOPOROSIS INTERNATIONAL, 2004, 15 : S119 - S120
[43] Osteoporosis, vertebral fractures and metabolic syndrome in postmenopausal women
El Maghraoui, Abdellah
Rezqi, Asmaa
El Mrahi, Salwa
Sadni, Siham
Ghozlani, Imad
Mounach, Aziza
BMC ENDOCRINE DISORDERS, 2014, 14
[44] Erratum to: A meta-analysis of the effect of strontium ranelate on the risk of vertebral and non-vertebral fracture in postmenopausal osteoporosis and the interaction with FRAX®
J. A. Kanis
H. Johansson
A. Oden
E. V. McCloskey
Osteoporosis International, 2011, 22 (8) : 2357 - 2358
[45] A new treatment for the reduction of vertebral and non-vertebral fractures in post-menopausal women with osteoporosis
Reginster, JY
Brixen, K
Bianchi, G
Hensen, J
Balogh, A
Lorenc, R
Cannata, JB
Fardellone, P
ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S291 - S291
[46] Risedronate reduces vertebral fractures in postmenopausal women with osteoporosis
Jackson, R
Bensen, W
Ettinger, M
Eastell, R
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2000, 48 (08) : S85 - S85
[47] Osteoporosis, vertebral fractures and metabolic syndrome in postmenopausal women
Abdellah El Maghraoui
Asmaa Rezqi
Salwa El Mrahi
Siham Sadni
Imad Ghozlani
Aziza Mounach
BMC Endocrine Disorders, 14
[48] Lasofoxifene reduced vertebral fractures in postmenopausal women with osteoporosis
Crandall, Carolyn J.
ANNALS OF INTERNAL MEDICINE, 2010, 153 (02)
[49] Sustained 5-year vertebral and non-vertebral fracture risk reduction with strontium ranelate in elderly women with osteoporosis
Seeman, E
Vellas, B
Benhamou, CL
Aquino, JP
Semler, J
Kaufman, JM
Hoszowski, K
Varela, AR
Fiore, CE
Brixen, K
Reginster, JY
Boonen, S
OSTEOPOROSIS INTERNATIONAL, 2006, 17 (06) : 953 - 953
[50] Romosozumab reduces incidence of new vertebral fractures across severity grades among postmenopausal women with osteoporosis
Geusens, Piet
Feldman, Robert
Oates, Mary
Thomas, Thierry
Makras, Polyzois
Jakob, Franz
Langdahl, Bente
Wang, Zhenxun
Rojeski, Maria
Libanati, Cesar
BONE, 2022, 154

← 1 2 3 4 5 →